1
For Private Circulation Only
Tech
nical and Derivative
s
Review
|September 30, 2022
All’s well that ends well, Nifty reclaims 17000
Sensex (57427) / Nifty (17094)
Source: Tradingview.com
Future outlook
Over the weekend, global markets felt a tremor after US Dollar Index surpassing alarming levels which obviously has a negative
correlation with equity markets. We started the week with a decent downside gap on Monday amid global weakness. As the day
progressed, the selling augmented across the broader market to test the psychological level of 17000. On the following session,
markets had a positive start which eventually got sold into. In fact, around the mid-week, the Nifty finally sneaked below 17000 to
even enter sub-16800 territory. On Friday, market had a litmus test ahead of the RBI Monetary policy as the Nifty was placed slightly
below key support of 16800. Market participants were hoping for some aid from this event and RBI Governor did not disappoint this
time as we not only witnessed a V-shaped recovery post the policy; but also went on to reclaim 17000 with some authority.
With Friday’s smart rally, Nifty almost engulfed entire week’s traded down move and hence, restricted the weekly losses tad above a
percent. Markets were extremely oversold, but they were reluctant to rebound as global weakness persisted throughout the week.
Post the RBI Monetary policy, we have managed to reverse precisely from a key support zone and if global markets support, we may
see this relief getting extended in the coming week as well. Technically speaking, the daily time frame exhibits a Bullish Engulfing’
pattern and on weekly chart, ‘Dragonfly Doji’ is clearly visible. Importantly, Nifty managed to defend the ‘20-EMA’ (on a closing
basis) on weekly chart, which is an indication of some strength. Going forward, a move beyond 17200 on a closing basis would
strengthen the recovery rally. In this case, 17350 17500 levels cannot be ruled out. On the flipside, 16900 16750 has now
become a sacrosanct support zone for the bulls. We advise traders to keep a close tab on global developments and any favorable
cues on this front would certainly provide the much-needed push for our domestic markets. Till the time important levels are not
reclaimed, it’s better to stay positive but adopt one step at a time approach. Also, in case of an extended rebound, one can keep
focusing on recent beaten down heavyweight spaces like, Financials and Auto, that are likely to give a sustainable relief.
2
For Private Circulation Only
Tech
nical and Derivative
s
Review
|September 30, 2022
Volatility to persist, Long Short Ratio plunged to 13%
Nifty spot closed at 17094.35 this week, against a close of 17327.35 last week. The Put-Call Ratio has increased from 0.76 to 1.22
The annualized Cost of Carry is positive at 0.70%. The Open Interest of Nifty Futures decreased by 7.63%
Derivatives View
Nifty current month’s future closed with a premium of 8.85 against a premium of 8.50 points to its spot in the previous week. Next
month’s future is trading at a premium of 57.35 points.
The Indian equity market has seen a roller coaster week once again, wherein the benchmark index started with a decent gap down
and witnessed a sell-off throughout the week until the last trading session that almost engulfed the entire weeks traded-down
move. There have been mixed positions in the F&O space throughout the week, but on a net basis, shorts were added. Even the
rollover in Nifty and BankNifty stood at 78% and 82%, respectively, which is slightly lower compared to the previous series. On the
options front, piling up of positions is visible in the 16800-16700 put strikes, indicating it to be a strong demand zone. While on the
higher end, 17200-17400 call strikes have seen piling up of positions, which hints at a broad range movement in the near period. The
stronger hands have curbed their positions resulting in a plunging of the ‘Long Short Ratio’, to 13% from 20% WoW. Going ahead, it
is advisable to keep a close tab on global developments and be very selective for the next couple of trading sessions.
Scrip
OI
Futures
OI
Chg (%)
Price
Price
Chg(%)
AXISBANK 47037600 21.02 735.45 (4.52)
BERGEPAINT 7477800 10.23 620.25 (2.37)
HDFC 17947800 9.90 2299.60 (2.35)
MCDOWELL-N 19779375 7.95 847.20 (2.74)
CANFINHOME 6427200 7.73 482.80 (6.61)
Weekly change in OI
Long Fo
rmation
Scrip
OI
Futures
OI
Chg (%)
Price
Price
Chg(%)
INDIACEM 15103200 23.91 271.85 7.05
DABUR 11046250 14.77 574.55 1.02
GODREJCP 6091000 9.53 914.90 2.77
TORNTPHARM 1657000 4.51 1565.65 3.08
SUNPHARMA 23284100 1.35 951.10 3.34
3
For Private Circulation Only
Tech
nical and Derivative
s
Review
|September 30, 2022
Sameet Chavan
C
hief Analyst
Technical
& Derivati
ves
sameet.chavan@angelone.in
Sneha Seth Senior Analyst – Technical & Derivatives sneha.seth@angelone.in
Rajesh Bhosale Technical Analyst rajesh.bhosle@angelone.in
Osho Krishan Senior Analyst – Technical & Derivatives osho.krishan@angelone.in
Research Team Tel: 022 - 39357600 Website: www.angelone.in
For Technical Queries E-mail: technicalresearch-cso@angelone.in
For Derivative Queries E-mail: derivatives.desk@angelone.in
DISCLAIMER
Angel One Limited (hereinafter referred to as Angel”) is a registered Member of National Stock Exchange of India Limited, Bombay
Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and
Portfolio Manager and investment advisor with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel One
Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration
number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for
accessing /dealing in securities Market.
This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment
decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should
make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the
companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine
the merits and risks of such an investment.
Angel or its associates or research analyst or his relative may have actual/beneficial ownership of 1% or more in the securities of the
subject company at the end of the month immediately preceding the date of publication of the research report. Neither Angel or its
associates nor Research Analysts or his relative has any material conflict of interest at the time of publication of research report.
Angel or its associates might have received any compensation from the companies mentioned in the report during the period
preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate
finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in
the normal course of business. Angel or its associates did not receive any compensation or other benefits from the companies
mentioned in the report or third party in connection with the research report. Neither Angel nor its research analyst entity has been
engaged in market making activity for the subject company.
Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and
trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's
fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate
the contrary view, if any.
The information in this document has been printed on the basis of publicly available information, internal data and other reliable
sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this
document is for general guidance only. Angel One Limited or any of its affiliates/ group companies shall not be in any way responsible
for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel One
Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make
any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel
4
For Private Circulation Only
Tech
nical and Derivative
s
Review
|September 30, 2022
One Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory,
compliance, or other reasons that prevent us from doing so.
This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced,
redistributed or passed on, directly or indirectly.
Neither Angel One Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in
connection with the use of this information. Angel or its associates or Research Analyst or his relative might have financial interest
in the subject company. Research analyst has not served as an officer, director or employee of the subject company.